Ubs Group Ag Cyclacel Pharmaceuticals, Inc. Transaction History
Ubs Group Ag
- $527 Billion
- Q4 2024
A detailed history of Ubs Group Ag transactions in Cyclacel Pharmaceuticals, Inc. stock. As of the latest transaction made, Ubs Group Ag holds 84 shares of CYCCP stock, worth $0. This represents 0.0% of its overall portfolio holdings.
Number of Shares
84Holding current value
$0% of portfolio
0.0%Shares
21 transactions
Others Institutions Holding CYCCP
# of Institutions
3Shares Held
178Call Options Held
0Put Options Held
0About Cyclacel Pharmaceuticals, Inc.
- Ticker CYCCP
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 12,497,400
- Market Cap $16.5M